Transforming the Care of Patients With Non-Small-Cell Lung Cancer: Optimizing Immune Checkpoint Inhibitor Therapy

Share

Program Content

  • Optimizing Immune Checkpoint Inhibitor
    Transforming the Care of Patients With Non-Small-Cell Lung Cancer: Optimizing Immune Checkpoint Inhibitor Therapy
    Slideset
    Congratulations: You achieved a completion on 04/09/2022
    View Activity

Supporters

Bristol-Myers Squibb

Genentech, a member of the Roche Group

Merck Sharp & Dohme Corp

Regeneron Pharmaceuticals, Inc

Sanofi